Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Methylthioninium

EU orphan designation number: EU/3/10/807   
Active ingredient: Methylthioninium
Indication: Treatment of frontotemporal dementia with parkinsonism-17
Sponsor: TauRx Therapeutics Europe Ltd
395 King Street, Aberdeen, AB24 5RP United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Orphan designation EMA/OD/125/10 (2010)8592 of 26/11/2010
17/02/2012 Transfer of orphan designation EMA/OD/125/10/T/01 (2012)1107 of 15/02/2012
11/08/2016 Transfer of orphan designation EMA/OD/125/10/T/02 (2016)5282 of 09/08/2016
22/01/2018 Change of name and/or address of sponsor